- eggNOG
- Preferred name: ALDH2B1 | Seed ortholog: 51240.A0A2I4HDF9 | COG: COG1012 | eggNOG OG: Aldedh@131567|EPR-25, Aldedh@3193|dYY-39, Aldedh@3398|AHkC-48
- Gene Ontology
- GO:0001523 retinoid metabolic process; GO:0001568 blood vessel development; GO:0001756 somitogenesis; GO:0001822 kidney development; GO:0001889 liver development; GO:0001936 regulation of endothelial cell proliferation; GO:0001947 heart looping; GO:0002072 optic cup morphogenesis involved in camera-type eye development; GO:0002138 retinoic acid biosynthetic process; GO:0002931 response to ischemia; GO:0003007 heart morphogenesis; GO:0004029 aldehyde dehydrogenase (NAD+) activity; GO:0005634 nucleus; GO:0006001 fructose catabolic process; GO:0006067 ethanol metabolic process; GO:0006068 ethanol catabolic process; GO:0006081 aldehyde metabolic process; GO:0006117 acetaldehyde metabolic process; GO:0006540 GABA shunt; GO:0006776 vitamin A metabolic process; GO:0006979 response to oxidative stress; GO:0007368 determination of left/right symmetry; GO:0007494 midgut development; GO:0007507 heart development; GO:0007626 locomotory behavior; GO:0008150 biological_process; GO:0008284 positive regulation of cell population proliferation; GO:0008285 negative regulation of cell population proliferation; GO:0008631 intrinsic apoptotic signaling pathway in response to oxidative stress; GO:0008637 apoptotic mitochondrial changes; GO:0009410 response to xenobiotic stimulus; GO:0009449 GABA biosynthetic process; GO:0009507 chloroplast; GO:0009855 determination of bilateral symmetry; GO:0009952 anterior/posterior pattern specification; GO:0009954 proximal/distal pattern formation; GO:0010628 positive regulation of gene expression; GO:0014032 neural crest cell development; GO:0016331 morphogenesis of embryonic epithelium; GO:0018937 nitroglycerin metabolic process; GO:0021522 spinal cord motor neuron differentiation; GO:0021575 hindbrain morphogenesis; GO:0021768 nucleus accumbens development; GO:0021915 neural tube development; GO:0021983 pituitary gland development; GO:0022010 central nervous system myelination; GO:0022011 myelination in peripheral nervous system; GO:0030182 neuron differentiation; GO:0030324 lung development; GO:0030326 embryonic limb morphogenesis; GO:0030392 fructosamine catabolic process; GO:0030900 forebrain development; GO:0030902 hindbrain development; GO:0031016 pancreas development; GO:0031076 embryonic camera-type eye development; GO:0031101 fin regeneration; GO:0032355 response to estradiol; GO:0032496 response to lipopolysaccharide; GO:0032526 response to retinoic acid; GO:0032570 response to progesterone; GO:0032870 cellular response to hormone stimulus; GO:0033189 response to vitamin A; GO:0033339 pectoral fin development; GO:0033574 response to testosterone; GO:0034097 response to cytokine; GO:0035094 response to nicotine; GO:0035115 embryonic forelimb morphogenesis; GO:0035799 ureter maturation; GO:0036438 maintenance of lens transparency; GO:0039023 pronephric duct morphogenesis; GO:0042420 dopamine catabolic process; GO:0042472 inner ear morphogenesis; GO:0042572 retinol metabolic process; GO:0042573 retinoic acid metabolic process; GO:0042574 retinal metabolic process; GO:0042904 9-cis-retinoic acid biosynthetic process; GO:0042905 9-cis-retinoic acid metabolic process; GO:0043010 camera-type eye development; GO:0043065 positive regulation of apoptotic process; GO:0043066 negative regulation of apoptotic process; GO:0043584 nose development; GO:0044849 estrous cycle; GO:0045471 response to ethanol; GO:0046185 aldehyde catabolic process; GO:0048048 embryonic eye morphogenesis; GO:0048149 behavioral response to ethanol; GO:0048318 axial mesoderm development; GO:0048339 paraxial mesoderm development; GO:0048384 retinoic acid receptor signaling pathway; GO:0048385 regulation of retinoic acid receptor signaling pathway; GO:0048386 positive regulation of retinoic acid receptor signaling pathway; GO:0048546 digestive tract morphogenesis; GO:0048566 embryonic digestive tract development; GO:0048593 camera-type eye morphogenesis; GO:0048703 embryonic viscerocranium morphogenesis; GO:0048738 cardiac muscle tissue development; GO:0048793 pronephros development; GO:0050885 neuromuscular process controlling balance; GO:0051289 protein homotetramerization; GO:0055093 response to hyperoxia; GO:0060013 righting reflex; GO:0060166 olfactory pit development; GO:0060324 face development; GO:0060325 face morphogenesis; GO:0061131 pancreas field specification; GO:0070384 Harderian gland development; GO:0071300 cellular response to retinoic acid; GO:0071398 cellular response to fatty acid; GO:0072015 podocyte development; GO:0110095 cellular detoxification of aldehyde; GO:0120163 negative regulation of cold-induced thermogenesis; GO:1902882 regulation of response to oxidative stress; GO:1903179 regulation of dopamine biosynthetic process; GO:1904639 cellular response to resveratrol; GO:1905627 regulation of serotonin biosynthetic process; GO:2000377 regulation of reactive oxygen species metabolic process; GO:2001038 regulation of cellular response to drug
- KEGG
- EC: ec:1.2.1.3 | KO: K00128 | Pathway: 00010, 00053, 00071, 00280, 00310, 00330, 00340, 00380, 00410, 00561, 00620, 00770, 01100, 01110, 01240 | Module: M00135, M00913 | BRITE: 00001, 01000